D-1052-2020 Class II Terminated

Recalled by Matthew 7:25 Inc Dba Thrive Pharmacy — Jacksonville, FL

FDA drug recall D-1052-2020 was initiated by Matthew 7:25 Inc Dba Thrive Pharmacy on Mar 10, 2020 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated Jun 2, 2023). Affected quantity: 71 troches.

Recall Details

Product Type
Drugs
Report Date
Apr 1, 2020
Initiation Date
Mar 10, 2020
Termination Date
Jun 2, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
71 troches

Product Description

Buprexone Banana cream 6-0.6 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida

Reason for Recall

Subpotent Drug

Distribution Pattern

Florida

Code Information

Lot: 190918B Exp. 03/16/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1052-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1052-2020. Report a data issue: hello@regdatalab.com.